Key result
Complete reverse remodeling after CRT linked to ~52% lower mortality vs no remodeling.
Why the study?
The prognostic implications of improved left atrial function in addition to improved left ventricular function after cardiac resynchronization therapy implantation were unknown.
Does complete reverse remodelling (improvement in both LARS and LV GLS) after CRT implantation improve survival in patients with heart failure?
Observational (n=923)
No
Does complete reverse remodelling (improvement in both LARS and LV GLS) after CRT implantation improve survival in patients with heart failure?
Hazard Ratio: 0.477 (95% CI 0.362–0.628)
Absolute Event Rate: 24% vs 36%
p-value: p=<0.001
Integrated assessment of left atrial and left ventricular deformation imaging at 6 months post-CRT provides incremental prognostic value for survival over conventional echocardiographic indices.
Complete reverse remodelling post-CRT was associated with lower mortality; extends LA/LV strain for risk stratification but leaves causal benefit open.
AIMS: Left atrial (LA) function is a marker of prognosis in patients with heart failure. The prognostic implications of an improvement in LA function in addition to an improvement in left ventricular (LV) function after cardiac resynchronization therapy (CRT) implantation are unknown. This study aimed to evaluate the prognostic value of a significant change in LA reservoir strain (RS) and/or LV global longitudinal strain (GLS) after initiation of CRT. METHODS AND RESULTS: LARS and LVGLS were measured with speckle-tracking echocardiography. Significant improvement in LARS and LVGLS was defined as a percentage change of +5% and +20% at 6 months after CRT implantation, respectively. Patients were divided into three groups: no significant reverse remodelling (no improvement in LARS and LVGLS), incomplete reverse remodelling (improvement in LARS or LVGLS), and complete reverse remodelling (improvement in LARS and LVGLS). The primary endpoint was all-cause mortality. A total of 923 patients (mean age 65 ± 10 years, 77% male) were included, of which 221 (24%) had complete reverse remodelling, 414 (45%) incomplete reverse remodelling, and 288 (31%) no significant reverse remodelling. Five-years' mortality was 24%, 29%, and 36% for patients with complete, incomplete, and no significant reverse remodelling, respectively (P < 0.001). On multivariable analysis, complete reverse remodelling (hazard ratio 0.477; 95% confidence interval: 0.362-0.628; P < 0.001) was associated with the lowest risk of mortality. CONCLUSIONS: Patients with complete reverse remodelling have a lower mortality risk than those showing incomplete or no significant reverse remodelling. The use of integrated LA and LV deformation imaging may improve risk-stratification of CRT recipients.
No takes yet. Share an insight, caveat, or question.
Stassen et al. (2022) conducted an observational in Heart failure (n=923). Complete reverse remodelling (improvement in LARS and LVGLS) vs. No significant reverse remodelling was evaluated on All-cause mortality (HR 0.477, 95% CI 0.362-0.628, p=<0.001). Complete reverse remodelling 6 months after CRT implantation was associated with a significantly lower risk of all-cause mortality compared to no significant reverse remodelling (HR 0.477).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: